Regulation of chondrocyte differentiation by actin-severing protein adseverin  by Nurminsky, Dmitry et al.
02 (2007) 427–437
www.elsevier.com/locate/ydbioDevelopmental Biology 3Regulation of chondrocyte differentiation by actin-severing protein adseverin
Dmitry Nurminsky, Cordula Magee, Lidia Faverman, Maria Nurminskaya ⁎
Tufts University School of Medicine, Department of Anatomy and Cellular Biology, 136 Harrison Avenue Boston, MA 02111, USA
Received for publication 11 August 2006; revised 25 September 2006; accepted 29 September 2006
Available online 6 October 2006Abstract
The importance of actin organization in controlling the chondrocyte phenotype is well established, but little is known about the cytoskeletal
components regulating chondrocyte differentiation. Previously, we have observed up-regulation of an actin-binding gelsolin-like protein in
hypertrophic chondrocytes. We have now identified it as adseverin (scinderin). Adseverin is drastically up-regulated during chondrocyte
maturation, as shown by Northern blot analysis, in situ hybridization, and real-time RT-PCR. Its expression is positively regulated by PKC and
MEK signaling as shown by inhibitory analyses. Over-expression of adseverin in non-hypertrophic chondrocytes causes rearrangement of the
actin cytoskeleton, a change in cell morphology, a dramatic (3.5-fold) increase in cell volume, and up-regulation of Indian hedgehog (Ihh) and of
collagen type X—all indicative of chondrocyte differentiation. These changes are mediated by ERK1/2 and p38 kinase pathways. Thus, adseverin-
induced rearrangements of the actin cytoskeleton may mediate the PKC-dependent activation of p38 and Erk1/2 signaling pathways necessary for
chondrocyte hypertrophy, as evidenced by changes in cell morphology, increase in cell size and expression of the chondrocyte maturation markers.
These results demonstrate that interdependence of cytoskeletal organization and chondrogenic gene expression is regulated, at least in part, by
actin-binding proteins such as adseverin.
© 2006 Elsevier Inc. All rights reserved.Keywords: Chondrocyte; Differentiation; Actin cytoskeleton; AdseverinIntroduction
Endochondral bone formation is a multi-step process
during which condensed mesenchymal cells differentiate into
hypertrophic, non-proliferating chondrocytes. The extracellu-
lar matrix surrounding the hypertrophic chondrocytes
becomes calcified and replaced with bone (Stocum et al.,
1979; Poole et al., 1989). Chondrocyte differentiation is a
precisely regulated process that involves proliferation,
hypertrophic differentiation, mineralization and apoptosis.
Disruption of these events can result in various skeletal
diseases and growth disorders (Zelzer and Olsen, 2003). The
control of chondrocyte differentiation involves multiple
extracellular and intracellular signaling molecules (reviewed
in Karsenty and Wagner, 2002; You et al., 2001; Haroon et
al., 1999; Nakajima et al., 2004).Abbreviations: NH, non-hypertrophic chondrocytes; HYP, hypertrophic
chondrocytes; Ihh, Indian hedgehog.
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doi:10.1016/j.ydbio.2006.09.052In vivo, chondrocyte differentiation is accompanied by both
drastic changes in cell shape – from a fibroblastic to a round
morphology (von der Mark and von der Mark, 1977) – and a
significant increase in cell volume (Wilsman et al., 1996). The
increase in cell diameter is one of the first indicators of
chondrocyte maturation, and in vivo it precedes terminal
differentiation by several days (Hirsch et al., 1996). A change
in cell shape (rounding up), usually associated with a decreased
cell-substratum interaction, is required for induction and/or
maintenance of the chondrocyte phenotype, as has been
demonstrated in numerous in vitro studies (reviewed in Daniels
and Solursh, 1991, and in Cancedda et al., 1995; Benya and
Shaffer, 1982; Glowacki et al., 1983). Chondrocyte phenotype
is affected by cell shape indirectly, and in fact it is regulated by
actin cytoskeleton (Zanetti and Solursh, 1984; Brown and
Benya, 1988). Further studies have confirmed the importance of
actin organization in controlling the chondrocyte phenotype.
For example, actin-disrupting compounds, such as cytochalasin
D, stimulate chondrogenesis (Loty et al., 1995; Woods et al.,
2005). However, to date, the molecular mechanisms responsible
for the interdependence of chondrocyte differentiation status
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little is known about the chondrocyte-specific intracellular
regulators of cytoskeletal rearrangements.
In various cell types, the dynamics of filamentous actin (F-actin)
is orchestrated by a variety (more than 60 classes) of actin-binding
proteins that function downstream of the Rho-family GTPases
(reviewed in Tojima and Ito, 2004). Many of these proteins are
ubiquitously expressed, while others are up-regulated at a particular
developmental stage or in a tissue-specific manner. Previously, we
reported an up-regulation of a gelsolin-like protein in hypertrophic
versus non-hypertrophic chondrocytes (Nurminskaya and Linsen-
mayer, 1996). The gelsolin superfamily of actin-binding proteins
includes gelsolin, villin, adseverin (also named scinderin), capG,
advillin, supervillin and flightless I. Members of this family control
actin organization by severing filaments, capping filament ends and
nucleating actin assembly in a calcium-dependent manner (Yin,
1987). They are found in a wide range of vertebrate, lower
eukaryotic and plant cells, and their functions vary significantly:
from remodeling actin filaments to specific non-overlapping roles
in various cellular processes controlling cell motility, apoptosis,
phagocytosis and even gene regulation (reviewed in Kwiatkowski,
1999; Silacci et al., 2004; McGough et al., 2003).
In the present study, we show that adseverin (scinderin) is
dramatically up-regulated during chondrocyte maturation, and
that in vivo expression of adseverin is restricted to the pre-
hypertrophic and hypertrophic cartilage of the embryonic
growth plate. On the contrary, gelsolin expression remains
constant during chondrocyte differentiation. We further
demonstrate that expression of adseverin is controlled by
the Ca2+-dependent protein kinase pathway (PKC), known to
be essential in maintaining the chondrogenic phenotype (Yoon
et al., 2002). Elevated levels of adseverin result in a
significant (over 3-fold) increase in chondrocyte cell size.
Moreover, adseverin acts as an important regulator of
chondrocyte differentiation, and over-expression of this
protein in non-hypertrophic chondrocytes is sufficient to
cause a decrease in cell proliferation and to promote
differentiation, as evidenced by the up-regulation of Indian
hedgehog (Ihh) and collagen type X. These changes are
accompanied by the activation of the mitogen-activated
protein (MAP) kinases ERK1/2 and p38, known regulators
of chondrogenesis (Zhen et al., 2001; Bobick and Kulyk,
2004). Our data suggest that in chondrocytes, adseverin
regulates the onset of hypertrophy in a MAPK-dependent
manner. The proposed role of adseverin in the regulation of
cell differentiation is not limited to chondrocytes: recently it
has been implicated in the differentiation of megakaryoblastic
leukemia cells (Zunino et al., 2001). Thus, the actin-binding
proteins, and adseverin in particular, represent an integral part
of the differentiation program in a number of cell lineages.
Materials and methods
Chondrocyte culture
Cartilages were dissected from 14-day-old chicken embryos (Spafas Inc.,
Norwich, CT). Hypertrophic chondrocytes were from the hypertrophic zone
three (Schmid and Conrad, 1982) of the tibia. Non-hypertrophic chondrocyteswere from the caudal one-third of the sternum.We employ sternum in our studies
as the tissue source of non-hypertrophic chondrocytes because non-hypertrophic
cells from the resting zone of the growth plate differentiate and initiate collagen
type X very rapidly in cultures. A significant number of collagen type X-positive
cells (up to 20%) can be detected immunohistologically in the overnight cultures
of resting chondrocytes (Nurminskaya et al., 2003). Cells were maintained as
previously described (Nurminskaya et al., 1998). To initiate differentiation of
non-hypertrophic chondrocytes, ascorbic acid (50 μg/ml) was added to the
culturemedium (Tacchetti et al., 1987; Gerstenfeld and Landis, 1991), whichwas
changed every other day over the period of 5 days. 3D collagen gels were made
from Vitrogen-100 solution (Cohesion, CA) according to manufacturer's
instructions.
Kinase inhibitors were obtained from Calbiochem (San Diego, CA). All
drugs were dissolved in dimethyl sulfoxide (DMSO) and preserved. The final
concentration of DMSO was ≤0.1%. The final concentrations of kinase
inhibitors were as follows: p38 inhibitor SB202190 at 15 μM, MEK inhibitor
U0126 at 5 μM and PKC inhibitor bisindolylmaleimide at 1 μM.
Preparation of RNA, Northern analysis and real-time PCR
Total RNA was isolated with Trizol reagent (GIBCO BRL). RNA samples
(20 μg) were subjected to electrophoresis through 1% agarose/2.2 M
formaldehyde gels and transferred to a HybondN filter (Amersham Corp.).
Hybridization was performed as described previously (Nurminskaya et al.,
1998). First-strand cDNA was synthesized with SuperScript III (Invitrogen)
using 0.5–1 μg of total RNA and oligo-(dT) primer. 1/50 part of the 15-μl
reverse transcription reaction was used as the template for the 25 μl real-time
PCR reaction. PCR reactions were performed in triplicates in the 5700 Sequence
Detector (ABI) using the QuantiTect SYBR Green PCR mix (Qiagen).
In situ hybridization
Tibiotarsi from 14-day-old chicken embryos (Spafas Inc., Norwich, CT),
fixed for 3 h in 4% PFA, were embedded in paraffin wax. Tissues were cut
into 6-μm sections and mounted on Vectabond-coated slides (Vector
Laboratories, Burlingame, CA). Preparation of riboprobes and hybridization
were performed as previously described (Nurminskaya et al., 1998). Signal
was detected with alkaline phosphatase conjugated anti-digoxigenin antibody
(Boehringer Mannheim Corp., Indianapolis, IN) and NBT/BCIP.
5′- and 3′-RACE, DNA sequencing
To extend the lengths of the partial cDNA sequence for gelsolin-like protein,
isolated by subtractive hybridization (Nurminskaya and Linsenmayer, 1996), 5′-
and 3′-RACE was performed, using the Marathon cDNA Amplification kit
(CLONTECH Laboratories, Inc., Palo Alto, CA). The extended, amplified
products were cloned into the plasmid pCRII (TA cloning kit; Invitrogen). For
each RACE product, 24–48 colonies were picked and amplified by PCR using
the same insert-specific primers. The positive clones were then analyzed for
insert size by PCR amplification with vector primers. The longest clones for 5′-
and 3′-RACE products were sequenced from both strands after obtaining sets of
gamma-delta transposon insertions (Strathmann et al., 1991). Sequencing was
performed in the 373A automated DNA sequencer (PE Applied Biosystems,
Foster City, CA) using the DyePrimer Cycle Sequencing kits. The results were
analyzed with the Sequencher software (GeneCodes Corp., Ann Arbor, MI). The
3.12-kb full-length cDNA sequence was submitted to GenBank accession no.
DQ020143.
Vector construction, transfection and immunochemical analyses
An adseverin-red fluorescent protein expression vector (pAdseverin-Red)
was constructed using the pDsRed vector (Clontech). Transient transfections
were performed using Fugene reagent (Roche). 7×104 hypertrophic chondro-
cytes or 7×103 non-hypertrophic chondrocytes were transfected with 1 μg of
DNA according to the manufacturer's instructions. At intervals after transfec-
tion, the transfected cultures were analyzed by immunofluorescence and
immunoblotting. For immunofluorescence, the cells were fixed in 4% PFA for
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X collagen mAb X-AC9 (Schmid and Linsenmayer, 1985), followed by FITC-
conjugated secondary anti-mouse antibodies. For analysis of filamentous actin,
cells were fixed with ice-cold acetone and stained with FITC-labeled phalloidin
(Sigma). The nuclei were visualized by Hoechst staining.
Immunoblotting
For immunoblotting, the cell cultures of non-hypertrophic chondrocytes
transfected with either pAdseverin-Red or the control original pDsRed were
sorted by FACS. Equal aliquots of transfected cells were used for analysis of
monomeric/fibrillar actin, as described (Beaulieu et al., 2005). Briefly,
monomeric actin was extracted with PBS by the freeze/thaw cycle. The
remaining filamentous actin was extracted with 1% Triton X-100. Protein
samples were analyzed for actin by Western blot. The monoclonal antibody
JLA20 developed by Dr. Lin was obtained from the Developmental Studies
Hybridoma Bank (developed under the auspices of the NICHD and maintained
by The University of Iowa).
Analysis of the MAP kinase pathway in sorted, transfected non-hypertrophic
chondrocytes was performed with p44/42 MAP kinase, SAPK/JNK, p38 MAP
kinase, phospho-p44/42 MAP kinase (Thr202/204), phospho-SAPK/JNK
(Thr183/185) and phospho-p38 (Thr180/182) antibodies obtained from Cell
Signaling (Beverly, MA). Beta-tubulin was detected with monoclonal TUB 2.1
antibody (Sigma).Results
Cloning of chicken adseverin
In our previous survey of genes differentially expressed in
hypertrophic versus non-hypertrophic chondrocytes (Nurmins-
kaya and Linsenmayer, 1996), we described a 160-bp cDNA
fragment encoding a gelsolin family protein. To further
characterize this protein expressed in hypertrophic chondro-
cytes, we obtained the full-length cDNA from this cell type by
RACE (Rapid Amplification of cDNA Ends) with gene-
specific primers designed using the original 160-bp sequence.
The resulting overlapping clones comprised a 3.12-kb full-
length cDNA (GenBank accession no. DQ020143). The
2169-bp open reading frame encodes a protein of 722 amino
acid residues and displays the six repeated, homologous
conserved domains (G1–G6) characteristic of the gelsolin
family proteins (Kwiatkowski et al., 1986; Way and Weeds,
1988). Because the protein shares higher levels of homology
with mammalian adseverins (overall homology of 78% with
mouse adseverin and 81% with bovine adseverin) than with
chicken gelsolin (61%), we identify the cloned molecule as
chicken adseverin.
Earlier studies have shown that in mammalian adseverin
(also named scinderin), the G1 domain contains the G-actin-
binding sites, while the G2 domain is responsible for the actin
filament binding essential for the actin-severing activity
(Sakurai et al., 1991). Chicken adseverin most likely
possesses the same actin-binding properties as mammalian
adseverin, based on the 89% homology between the G1 and
G2 domains of the avian and the mouse proteins (Fig. 1A).
However, cell-type-specific forms of adseverin with differing
ability to regulate the actin cytoskeleton have been described,
for example, in lymphocytes (Robbens et al., 1998). To
evaluate the potential of chicken adseverin expressed inchondrocytes to affect the actin cytoskeleton, we over-
expressed a fusion protein comprising adseverin and fluor-
escent DsRed in chondrocytes by transient transfections, and
analyzed F-actin in the transfected cells using phalloidin, a
probe for filamentous actin (Fig. 1B). Elevated levels of
adseverin caused a significant reduction in F-actin as
compared to non-transfected cells, suggesting that chicken
adseverin is able to sever actin filaments, similar to its
mammalian homolog.
Further, we analyzed the ratio of monomeric to fibrillar actin
in non-hypertrophic chondrocytes over-expressing adseverin by
Western blot analysis. Cells were transiently transfected with the
expression vector encoding either the Adseverin/DsRed fusion
protein (pAdseverin-DsRed), or the DsRed protein alone as a
control. Transfected cells were selectively amplified by 7 days of
growth in the G418-supplemented medium, and then collected
by fluorescent cytometry using the DsRed fluorescent marker.
Aliquots containing equal numbers of cells were allowed to
attach to cell culture plates, and the monomeric and the
filamentous actin forms were subsequently extracted (Beaulieu
et al., 2005). Western blot analysis confirmed a 55% (±6%)
increase in monomeric actin in cells over-expressing the
Adseverin-DsRed fusion protein versus cells over-expressing
the control DsRed protein, consistent with the observed
adseverin-induced disruption of actin filaments detected by
fluorescence microscopy (Fig. 1C).
Up-regulation of adseverin during chondrocyte hypertrophy
requires PKC signaling
Initially, adseverin was identified by subtractive hybridiza-
tion as one of the genes up-regulated in avian hypertrophic
versus non-hypertrophic chondrocytes (Nurminskaya and
Linsenmayer, 1996). In those studies, we have used the lower
1/3 of sterna as a source for the non-hypertrophic chondrocytes,
whereas the hypertrophic chondrocytes originated from the
hypertrophic zone of the tibial growth plate. To further confirm
an increase in adseverin expression during chondrocyte
maturation to hypertrophy, we employed several methods.
Northern blot analysis of mRNA from cultured non-hyper-
trophic sternal (NH) and from hypertrophic (Hyp) cells detected
a 3.2-kb adseverin transcript only in the hypertrophic
chondrocytes (Fig. 2A). On the contrary, gelsolin (another
member of the gelsolin protein family) is expressed at equal
levels in both cell types. Real-time PCR analysis of cells freshly
isolated from the cartilaginous tissues demonstrated a dramatic
340 (±37)-fold increase of adseverin mRNA in hypertrophic
chondrocytes as compared to non-hypertrophic cells (normal-
ized to beta-actin mRNA).
To substantiate that these data, obtained using cultured cells,
also correspond to the expression pattern of adseverin in vivo,
we performed in situ hybridization on the growth plate of 14-
day-old chicken embryos. A much stronger signal for adseverin
mRNA was detected in the pre-hypertrophic and hypertrophic
zones versus the resting and proliferating zones of the
embryonic growth plate (Fig. 2B). Thus, adseverin expression
is very low (if detectable at all) in the non-hypertrophic cartilage
Fig. 1. Actin filament-severing activity of chicken adseverin. (A) The chicken adseverin's repeating domains (G1–G6) are shown in comparison with the equivalent
domains of mouse adseverin. The numbers below the repeating domains indicate the homology between the two proteins (in %). Positions of gelsolin-like domains are
numbered above the protein molecule. (B) Over-expression of adseverin results in rearrangement of the actin cytoskeleton as evidenced by significant reduction of
filamentous actin in hypertrophic chondrocytes transfected with pAdseverin-DsRed. The adseverin-red fusion protein was detected by red fluorescence while
filamentous actin was detected with FITC-labeled phalloidin. (C) Over-expression of adseverin in non-hypertrophic chondrocytes increases levels of actin monomers.
Monomeric and fibrillar actin was isolated by sequential extraction from cells expressing either DsRed protein or adseverin-red fusion protein. Lysates of equal cell
number analyzed by Western blot.
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these data demonstrate that adseverin is specifically up-
regulated in pre-hypertrophic and hypertrophic chondrocytes
during the embryonic development of long bones.
Protein kinase C (PKC) signaling is essential for maintaining
of the chondrogenic phenotype (Yoon et al., 2002). To
determine whether adseverin expression during chondrocyte
hypertrophy is regulated by PKC, we analyzed the expression of
adseverin in differentiating chondrocytes in which PKC activity
was blocked with the highly selective PKC inhibitor bisindo-Fig. 2. Expression of adseverin is restricted to hypertrophic chondrocytes of the em
hypertrophic (NH) and hypertrophic chondrocytes (Hyp).The constitutive gene GA
embryonic growth plate with antisense adseverin RNA probe.lylmaleimide I. Non-hypertrophic chondrocytes were stimu-
lated to differentiate in the presence of ascorbic acid (Tacchetti
et al., 1987; Gerstenfeld and Landis, 1991) and treated with
bisindolylmaleimide I. Expression of adseverin and of other
characteristic markers of chondrocyte differentiation was
analyzed by real-time PCR. Two chondrogenic markers were
studied: Indian hedgehog (Ihh), characteristic for pre-hyper-
trophic chondrocytes (Wallis, 1996); and collagen type X,
specific for hypertrophic chondrocytes (Schmid and Linsen-
mayer, 1985). Chondrocyte differentiation was assessedbryonic growth plate. (A) Northern blot analysis of mRNA from cultured non-
PDH was used as a loading control. (B) In situ hybridization of the 14-day-old
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3A), and at the molecular level by up-regulation of Ihh, collagen
type X and adseverin (Fig. 3B, hatched bars). Inhibition of PKC
with bisindolylmaleimide I caused dedifferentiation of chon-
drocytes, as evidenced by fibroblastic cell morphology (Fig.
3A) and total inhibition of Ihh and collagen type X expression
(Fig. 3B, black bars), in agreement with earlier studies (Oh et
al., 2000). Similarly, expression of adseverin was averted in
bisindolylmaleimide-treated chondrocytes. Thus, adseverin up-
regulation is specifically linked to the chondrocyte maturation
program and is regulated by PKC, similar to other characteristic
markers of pre-hypertrophic and hypertrophic chondrocytes.
Over-expression of adseverin promotes changes in chondrocyte
morphology characteristic for hypertrophy
During hypertrophy, chondrocytes of the growth plate
undergo a 10- to 15-fold increase in volume, and this increase
in cell size can account for as much as 80% of the total increase
in bone length over 24 h (Wilsman et al., 1996; Farnum et al.,
2002). These changes in cell volume are likely to be associatedFig. 3. Adseverin expression is regulated by PKC activity. (A) Ascorbic acid-
induced differentiation of chondrocytes is prevented by PKC inhibitor
bisindolylmaleimide I, as evidenced by cell morphology. (B) Changes in
expression of Ihh, adseverin and collagen type X evaluated by real-time PCR
and normalized to beta-actin mRNA. Gene expression in non-hypertrophic
chondrocytes stimulated to differentiate with ascorbic acid (hatched bars) and in
ascorbic acid-treated cells grown in the presence of PKC inhibitor bisindo-
lylmaleimide I (black bars) were compared to mRNA levels in non-stimulated
non-hypertrophic chondrocytes (NH; white bars).with (or probably, caused by) rearrangement of the cytoskele-
ton. Since adseverin is the first actin-binding protein identified
as specifically up-regulated in hypertrophic chondrocytes, we
analyzed the ability of this protein to cause a cell size increase.
In parallel, we assessed the effect of actin-disrupting chemical
agents latrunculin and cytochalasin D. Chondrocytes were
transfected with either a pAdseverin-DsRed or the control
pDsRed expression vectors and grown in 3D collagen gels for
7 days. The 3D gels were employed for the analyses of cell
volume because in previous studies, no visible morphological
changes were detected in cells cultured on glass slides upon
cytochalasin D-induced disruption of F-actin (Pritchard and
Guilak, 2004). In addition, blocking actin polymerization
exhibits context-specific regulation of chondrogenic gene
expression and results in the difference of effects in 3D and
monolayered cultures (Woods and Beier, 2006). The diameter of
transfected cells was analyzed by fluorescent microscopy. Over-
expression of adseverin resulted in a significant ca. 50%
increase in cell diameter, corresponding to an approximately
3.5-fold increase in cell volume. Similar changes in chondro-
cyte cell size were induced by latrunculin and cytochalasin D
(Fig. 4A), suggesting that the observed adseverin-induced
hypertrophy of chondrocytes depends on cytoskeleton rearran-
gement. Our data may explain, at least in part the reported
enlargement of chondrocytes during differentiation (Farnum et
al., 2002), and identify adseverin as the first actin-binding
protein shown to be involved in this process.
In addition to the demonstrated ability to induce an increase
in chondrocyte cell volume when cells are cultured in collagen
gels, adseverin can cause dramatic changes in cell morphol-
ogy. When non-hypertrophic chondrocytes over-expressing
adseverin are grown in monolayers, they display the polygonal
morphology characteristic of hypertrophic cells (Fig. 4B). This
is in contrast to the fibroblast-like morphology of both non-
transfected cells and cells over-expressing the control protein
DsRed (Fig. 4B). The acquisition of the hypertrophic
phenotype by the non-hypertrophic cells over-expressing
adseverin supports the hypothesis on the interdependence of
cell size/shape, cytoskeleton arrangement and the program of
chondrocyte differentiation.
Adseverin regulates chondrocyte proliferation and
differentiation
Chondrocyte transition from the non-hypertrophic to hyper-
trophic stage is accompanied by a decline and eventual
cessation of proliferation. To assess the effect of adseverin on
proliferation rates of non-hypertrophic chondrocytes, we
isolated transfected non-hypertrophic chondrocytes, expressing
either Adseverin-DsRed fusion protein or DsRed, by fluores-
cent cytometry. Fluorescent cells were plated at a very low
density (500 cells/cm2) to allow for the growth of individual
colonies of transfected cells in the G418 selection medium.
Non-hypertrophic cells expressing the DsRed protein prolifer-
ated rapidly and formed extended colonies of fluorescent cells
with some cells demonstrating the fibroblast-like morphology
of dedifferentiated chondrocytes (Fig. 5A, right panel). On the
Fig. 4. Adseverin-induced changes in chondrocyte morphology. (A) Increase in cell diameter of non-hypertrophic chondrocytes induced by rearrangement of the actin
cytoskeleton resulting from exposure to latrunculin and cytochalasin D, or from over-expression of adseverin. Cells transfected with pDsRed or pAdseverin-DsRed
were grown in 3D collagen gels. Fluorescent cells were photographed and cell diameter was measured in pixels. At least 100 cells per condition were analyzed.
Experiment was repeated twice. (B) Over-expression of adseverin in non-hypertrophic chondrocytes (NH) alters the morphology of cells grown in monolayers,
inducing the polygonal phenotype characteristic for hypertrophic chondrocytes (Hyp; visualized by fluorescence of control DsRed protein). Cells expressing DsRed
protein retain the fibroblastic morphology characteristic for dedifferentiating chondrocytes.
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DsRed grew very slowly, with cells acquiring the hypertrophic
chondrocyte-like polygonal shape and/or rounding up, likely
due to the rearrangement of the actin cytoskeleton. (Fig. 5A, left
panel).
The decline in proliferation is associated with chondrocyte
maturation during differentiation. To address whether the
observed adseverin-induced limited growth in non-hypertrophic
chondrocytes is associated with an accelerated differentiation
towards hypertrophy, we analyzed the expression of Indian
hedgehog (Ihh), a marker of pre-hypertrophic chondrocytes,
and of collagen type X, specific for hypertrophic chondrocytes,
by real-time PCR in non-hypertrophic chondrocytes expressing
either Adseverin-DsRed or DsRed. FACS-sorted transfected
cells were grown for 10 days to allow for differentiation.
Hypertrophic chondrocytes isolated from the growth plate were
used as a positive control (Table 1). Non-hypertrophic
chondrocytes transfected with pDsRed as well as the non-
transfected cells (data not shown) expressed extremely low
levels of either Ihh or collagen type X after 10 days in culture.
Over-expression of adseverin in non-hypertrophic chondrocytes
induced expression of both genes. The most dramatic increase
in expression was detected for Ihh (with ca. 25-fold increase in
Ihh mRNA levels in the adseverin-expressing cells), whileexpression of type X collagen was increased but not to the
extraordinary high levels of this protein characteristic to mature
hypertrophic chondrocytes. These results indicate that transition
from the immature to the pre-hypertrophic stage of chondro-
genesis is more dependent on the cytoskeleton organization than
the final chondrocyte maturation.
Adseverin-induced chondrocyte differentiation is mediated by
ERK1/2 and p38 kinases
Chondrocyte differentiation is, in general, regulated by the
mitogen-activated protein (MAP) kinase signaling pathways.
Both the ERK1/2 and the p38 kinases are known to regulate
expression of Ihh in maturing chondrocytes (Haroon et al.,
1999). To determine whether these pathways mediate the
adseverin-induced expression of Ihh, we analyzed the levels of
activated (phosphorylated) ERK1/2 and p38 in non-hyper-
trophic chondrocytes over-expressing adseverin. Cells were
transfected with either pAdseverin-DsRed or pDsRed, allowed
to grow in the G418-selection medium for 10 days, and sorted
by FACS to enrich the analyzed samples with transfected cells.
Both the ERK1/2 and the p38 signaling pathways were
activated by over-expression of adseverin, as detected by
Western blot analysis (Fig. 5B). At the same time, no adseverin-
Fig. 5. Adseverin-induced accelerated chondrocyte differentiation is mediated by MAPK signaling. (A) Over-expression of adseverin in non-hypertrophic
chondrocytes slows down proliferation in these cells. FACS-sorted cells over-expressing either Adseverin-DsRed or DsRed control were plated at very low density,
and the growth of individual colonies was analyzed by fluorescent microscopy in 7-day-old cultures. (B) Over-expression of adseverin (Ads), but not of DsRed (Red),
induces activation of ERK 1/2 and p38 signaling pathways in non-hypertrophic chondrocytes detected by Western blot. (C) Expression levels of adseverin, Ihh and
collagen type X were compared in the absence or presence of the p38 inhibitor SB203590 (15 μM) and MEK1/2 inhibitor U0126 (5 μM) in non-hypertrophic
chondrocytes induced to differentiate with ascorbic acid. Inhibition of p38 kinase (black bars) results in decreased expression of collagen type X and Ihh (markers of
hypertrophic differentiation) but does not affect expression of adseverin, whereas inhibition of the MEK1/2–ERK1/2 pathway (grey bars) results in concurrent down-
regulation of adseverin and Ihh. All data represent averages and SD from three independent experiments (*p<0.05).
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(data not shown). These data identify ERK1/2 and p38 kinases
as molecular mediators of the adseverin-induced accelerated
chondrocyte differentiation, especially the transition into the
early hypertrophic stage characterized by expression of Ihh.
To determine the hierarchy and interdependence of adse-
verin-induced actin rearrangement and activation of MAP
kinases, we analyzed the expression of adseverin, Ihh and
collagen type X in differentiating chondrocytes exposed to
various kinase inhibitors. Non-hypertrophic chondrocytes were
grown for 5 days with ascorbic acid. Under these conditions, the
cells start to differentiate into hypertrophic chondrocytes and
initiate expression of Ihh, collagen type X and adseverin, as
determined by real-time PCR analysis (Fig. 5C, white bars).
Inhibition of p38 kinase with the specific inhibitor SB202190significantly decreased expression of Ihh and collagen type X
(Fig. 5B, black bars). These results are consistent with the
previously published data on the requirement of p38 kinase
activity for chondrocyte maturation, and for collagen type X
(You et al., 2001) as well as Ihh expression (Lai et al., 2005). At
the same time, inhibition of p38 kinase had little, if any, effect
on expression of adseverin (Fig. 5C, black bars). In combination
with the observed activation of p38 by adseverin expression
(Fig. 5B), these results imply that p38 kinase signaling is a
downstream target of the adseverin-induced rearrangements of
the actin cytoskeleton.
On the contrary, inhibition of ERKs by U0126, the inhibitor
of the upstream MEK kinase, caused an approximately 60%
concurrent decrease in expression of Ihh and adseverin (Fig. 5C,
grey bars). These results indicate that adseverin expression in
Table 1
Adseverin-induced expression of the markers of chondrocyte differentiation in
non-hypertrophic chondrocytes
Ihh Collagen type X
NH-DsRed 48±22 4±1
NH-Adseverin 1118±225 205±28
Hyp 358±198 7191±870
Transiently transfected non-hypertrophic chondrocytes were grown in the G418-
selection medium for 10 days, sorted by fluorescent cytometry and allowed to
differentiate for 5 days in the presence of ascorbic acid. Expression levels of Ihh
and collagen type X were analyzed by real-time PCR. Expression of the
analyzed genes in non-hypertrophic chondrocytes, freshly liberated from the
cartilage, were used as basal levels. Data are normalized to beta-actin.
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addition to the demonstrated regulation by PKC activity
(Fig. 3). This is in agreement with the recent findings of Oh
and co-authors (Oh et al., 2000) that ERK1/2-mediated PKC
signaling regulates chondrocyte differentiation. Activation of
ERK1/2 can lead to actin rearrangements (Sukezane et al.,
2005), and our data identify adseverin as a candidate mediator
of such rearrangements in chondrocytes. Interestingly, over-
expression of adseverin in non-hypertrophic chondrocytes
resulted in the activation of ERK1/2 (Fig. 5B), suggesting a
positive regulatory feedback that maintains ERK1/2 activity in
maturing chondrocytes.
In summary, we have observed that the actin-binding
protein adseverin is expressed in pre-hypertrophic and
hypertrophic chondrocytes of the embryonic growth plate.
Expression of adseverin in differentiating chondrocytes is
controlled by PKC-MEK signaling and leads to increased cell
size, decreased chondrocyte proliferation and induction of Ihh
and collagen type X expression, indicative of chondrocyte
differentiation. MAP kinases p38 and ERK1/2 mediate the
adseverin-induced accelerated differentiation of non-hyper-
trophic chondrocytes.
Discussion
The phenomenon of interdependence of cell shape, cytoske-
letal organization and chondrogenic phenotype has been well
established a few decades ago (reviewed in Cancedda et al.,
1995). A role for the actin cytoskeleton in chondrocyte
differentiation was implicated by the initial observations on
the ability of spherical chondrocytes cultured in agarose gels to
retain their chondrogenic phenotype, but to lose it when
cultured in monolayers or on fibronectin (Benya and Shaffer,
1982; Glowacki et al., 1983). Subsequent studies on the
disruption of actin microfilaments with cytochalasin D in chick
limb bud mesenchymal cells in subconfluent monolayers,
which resulted in cell rounding, loss of actin cables and
induction of chondrogenesis, confirmed the regulation of
chondrogenesis by the cytoskeleton (Zanetti and Solursh,
1984). The assembly and disassembly of the actin cytoskeleton
in response to the extracellular matrix is controlled by the small
Ras-related GTP-binding proteins RhoA, Rac1 and Cdc42.
(Hall, 2005). All of these have recently been implicated as
regulators of chondrocyte differentiation (Woods et al., 2005).Nevertheless, the molecular mechanisms underlying the
regulation of chondrocyte maturation by the actin cytoskeleton
are not clearly understood. In particular, surprisingly little is
known about the chondrocyte-specific actin-binding proteins
that regulate cytoskeletal rearrangement, despite the existence
of more than 60 classes of such proteins discovered in
eukaryotic cells (reviewed in Tojima and Ito, 2004). Up to
date, only filamins A and B have been shown to affect
endochondral ossification. Human patients with mutated
filamins are characterized by defects restricted to vertebral
segmentation, joint formation and endochondral ossification,
despite the ubiquitous expression of these proteins (Krakow et
al., 2004; Robertson et al., 2003). These studies further
reinforced the link between the actin cytoskeleton and
chondrogenesis; however, the chondrocyte-specific mechanism
responsible for the effect remained elusive.
Previously, we identified an actin-binding protein of the gelsolin
family as a product of one of the genes up-regulated during
chondrocyte differentiation (Nurminskaya and Linsenmayer, 1996).
Here, we identified this protein as adseverin. The expression pattern
of several proteins of the gelsolin family has been analyzed inmouse
development by in situ hybridization. This study detected only
adseverin, but not gelsolin or capG protein, in embryonic
endochondral bones (Arai and Kwiatkowski, 1999). We analyzed
the expression pattern of gelsolin and adseverin in cultured chicken
chondrocytes at different stages of maturation, and observed that
gelsolin is expressed at almost identical levels in non-hypertrophic
and hypertrophic chondrocytes, whereas adseverin is dramatically
up-regulated during the progression towards hypertrophy. The
restricted pattern of adseverin expression in the pre-hypertrophic and
hypertrophic zones of the embryonic growth plate was confirmed
usingNorthern blot analysis, real-timePCRand in situ hybridization.
Thus, adseverin represents an actin-binding protein of the gelsolin
family specifically up-regulated during chondrocyte hypertrophy.
Although adseverin is thought to regulate exocytosis in
chromaffin cells (Trifaro et al., 2002), its physiological role in
developing bones and in other tissues without significant
secretory activity remains unknown. Our data demonstrate
that adseverin may contribute to the chondrocyte enlargement
associated with hypertrophy (Barreto and Wilsman, 1994),
since over-expression of this protein in chondrocytes results
in an approximately 3.5-fold increase in cell volume. The
forced expression of adseverin in non-hypertrophic chondro-
cytes also induces a dramatic change in cell morphology, with
transfected cells grown in monolayers acquiring the poly-
gonal cell shape characteristic for hypertrophic chondrocytes.
These changes are accompanied by adseverin-induced actin
depolymerization, enrichment with actin monomers and
cytoskeletal rearrangements. In addition, premature expres-
sion of adseverin in non-hypertrophic chondrocytes results in
slower cell proliferation and acceleration of chondrocyte
maturation, as evidenced by the up-regulation of the specific
chondrogenic markers Ihh and collagen type X. The
adseverin-induced increase in Ihh expression in non-hyper-
trophic chondrocytes is more pronounced than that of type X
collagen, when compared to the endogenous levels of these
proteins in hypertrophic cells. This suggests that adseverin
Fig. 6. Scheme of the role of adseverin in the regulation of cytoskeleton-
dependent chondrocyte differentiation. Activation of PKC signaling in non-
hypertrophic chondrocytes induces adseverin expression in a MEK-dependent
manner. Expression of adseverin causes rearrangement of the actin cytoskeleton,
leading to chondrocyte maturation as evidenced by cell enlargement and
changes in cell morphology, and also by induced expression of Ihh and collagen
type X. The changes in gene expression are regulated by adseverin-induced
activation of the ERK1/2 and p38 kinase signaling pathways. Additionally,
MEK-ERK1/2 activity is required to maintain adseverin expression suggesting,
a regulatory positive feedback between these proteins.
435D. Nurminsky et al. / Developmental Biology 302 (2007) 427–437regulates the intermediate stages of chondrocyte differentia-
tion (transition from pre- to early hypertrophy), rather than
the final stage of maturation.
The expression of adseverin itself in chondrocytes appears to
be regulated by PKC-MEK signaling. Inhibition of PKC in
differentiating chondrocytes by bisindolylmaleimide I results in
morphological dedifferentiation and cessation of transcription
of adseverin and of the downstream markers of hypertrophy,
such as Ihh and collagen type X. Inhibition of MEK in these
cells with U0126 resulted in a significant (approximately 50%)
decrease in expression of the early hypertrophic genes, such as
adseverin and Ihh, thus suggesting a positive regulation of
chondrocyte maturation by this pathway. Earlier studies have
indicated that PKC signaling is required for chondrogenesis
(Chang et al., 1998; Oh et al., 2000; Yoon et al., 2002). The
precise role of the MEK-ERK cascade in the regulation of
chondrocyte differentiation remains controversial. Several
studies have demonstrated positive regulation of in vitro
chondrogenesis by this pathway (Murakami et al., 2004;
Nakajima et al., 2004), while others describe this cascade as a
negative modulator of cartilage differentiation (Chang et al.,
1998; Bobick and Kulyk, 2004; Seghatoleslami et al., 2003).
The discrepancy is in large part due to the employed kinase
inhibitors. The two most commonly used inhibitors of the
MEK-ERK cascade –U0126 and PD98059 – likely do not have
completely equivalent target specificities (Bobick and Kulyk,
2004) and confer opposite effects on chondrogenesis in a dose-
dependent manner (Seghatoleslami et al., 2003). In our studies,
we used U0126, which is known to inhibit chondrocyte
differentiation (Murakami et al., 2000; Stephens et al., 2004;
Nakajima et al., 2004); this inhibition resulted in down-
regulation of adseverin and Ihh. Thus, our analysis demon-
strated that treatment with the PKC-MEK-ERK pathway
inhibitors that impede chondrocyte differentiation results in
down-regulation of adseverin and of the downstream hyper-
trophy markers Ihh and (in the case of PKC inhibitor) collagen
type X. These data suggest a role for adseverin as a mediator of
pro-differentiation activity of the PKC-MEK-ERK pathway in
chondrocytes.
Up-regulation of adseverin results in changes in actin
cytoskeleton, and in expression of the components of the
chondrocyte differentiation program such as Ihh and collagen
type X. These events are probably linked by the p38 kinase
pathway. We demonstrated that elevated levels of adseverin
activate p38 kinase in chondrocytes. The p38 kinase is an
essential regulator of chondrocyte differentiation and is required
for Ihh and collagen type X expression (You et al., 2001;
Haroon et al., 1999; Nakajima et al., 2004). Modulations of p38
kinase signaling by the actin cytoskeleton have been proposed
for articular chondrocytes (Kim et al., 2003; Szondy et al.,
2003). In addition, the p38 kinase activity was implicated to
mediate chondrocyte maturation induced by the small GTPases
Rac1 and Cdc42, which affect actin cytoskeleton, in the
chondrogenic cell line ATDC5 (Woods et al., 2005). Taken
together, all these data suggest that the p38 kinase pathway may
represent the downstream target of adseverin, regulated through
the changes in the actin cytoskeleton.Our data also imply that adseverin regulates MEK-ERK1/2
signaling: over-expression of adseverin in chondrocytes results
in activation of ERK1/2. At the same time, MEK-ERK1/2
signaling is required for high levels of adseverin expression, as
discussed above. These observations suggest two signaling
events mediated by ERK1/2 contributing to chondrocyte
maturation. The first event, which requires PKC (Chang et al.,
1998), leads to initiation of chondrocyte progression to
hypertrophy and induction of pre-hypertrophic markers such
as adseverin and Ihh. Up-regulation of adseverin leads to actin
rearrangement and to the second activation of ERK1/2, which
probably accelerates chondrocyte hypertrophy. Progression of
chondrocyte maturation requires a coordinate regulation of the
small GTPases Rho and Rac1/Cdc42, which antagonistically
regulate chondrocyte proliferation, hypertrophy and apoptosis
(Woods et al., 2005). Intriguingly, ERK signaling can
coordinately regulate activity of Rac1 and RhoA in the required
fashion, as has been demonstrated in tumor cells (Vial et al.,
2003). Therefore, we propose a model (Fig. 6) in which
activation of PKC in non-hypertrophic chondrocytes induces
the genes of the early differentiation program, including the
actin-binding protein adseverin. Elevated levels of adseverin
cause the reorganization of the actin cytoskeleton, leading to the
activation of signaling through the p38 and ERK1/2 kinases.
(Alternatively, adseverin may stabilize or amplify the activity of
the MEK-ERK1/2 cascade during chondrocyte differentiation
by another, yet unknown, mechanism.) Activation of MAPK
436 D. Nurminsky et al. / Developmental Biology 302 (2007) 427–437signaling promotes chondrocyte hypertrophy, including the
morphological changes (e.g., changes in cell morphology and
increase in cell size) and the gene expression program (i.e.,
expression of markers of chondrocyte maturation).
Further studies of the physiological functions of adseverin in
embryonic endochondral bone formation will require genetic
models. Compensation between adseverin and the other
members of the gelsolin protein family expressed in cartilage,
such as gelsolin, may complicate the analysis of the individual
proteins. For example, gelsolin null mice develop normally
(Silacci et al., 2004). Generation of double knockout models
will further our understanding on the roles of gelsolin and
adseverin in the molecular mechanisms controlling bone
formation.
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